BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 23894366)

  • 1. Lycium barbarum (wolfberry) reduces secondary degeneration and oxidative stress, and inhibits JNK pathway in retina after partial optic nerve transection.
    Li H; Liang Y; Chiu K; Yuan Q; Lin B; Chang RC; So KF
    PLoS One; 2013; 8(7):e68881. PubMed ID: 23894366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of Lycium barbarum (Wolfberry) on alleviating axonal degeneration after partial optic nerve transection.
    Li HY; Ruan YW; Kau PW; Chiu K; Chang RC; Chan HH; So KF
    Cell Transplant; 2015; 24(3):403-17. PubMed ID: 25622224
    [TBL] [Abstract][Full Text] [Related]  

  • 3.
    Li HY; Huang M; Luo QY; Hong X; Ramakrishna S; So KF
    Cell Transplant; 2019 May; 28(5):607-618. PubMed ID: 30838886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of lycium barbarum (wolfberry) polysaccharides on preserving retinal function after partial optic nerve transection.
    Chu PH; Li HY; Chin MP; So KF; Chan HH
    PLoS One; 2013; 8(12):e81339. PubMed ID: 24339917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection of retinal ganglion cells and retinal vasculature by Lycium barbarum polysaccharides in a mouse model of acute ocular hypertension.
    Mi XS; Feng Q; Lo AC; Chang RC; Lin B; Chung SK; So KF
    PLoS One; 2012; 7(10):e45469. PubMed ID: 23094016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of the Nrf2/HO-1 antioxidant pathway contributes to the protective effects of Lycium barbarum polysaccharides in the rodent retina after ischemia-reperfusion-induced damage.
    He M; Pan H; Chang RC; So KF; Brecha NC; Pu M
    PLoS One; 2014; 9(1):e84800. PubMed ID: 24400114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A model to study differences between primary and secondary degeneration of retinal ganglion cells in rats by partial optic nerve transection.
    Levkovitch-Verbin H; Quigley HA; Martin KR; Zack DJ; Pease ME; Valenta DF
    Invest Ophthalmol Vis Sci; 2003 Aug; 44(8):3388-93. PubMed ID: 12882786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transcription factor c-jun is activated in retinal ganglion cells in experimental rat glaucoma.
    Levkovitch-Verbin H; Quigley HA; Martin KR; Harizman N; Valenta DF; Pease ME; Melamed S
    Exp Eye Res; 2005 May; 80(5):663-70. PubMed ID: 15862173
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitative retinal protein analysis after optic nerve transection reveals a neuroprotective role for hepatoma-derived growth factor on injured retinal ganglion cells.
    Hollander A; D'Onofrio PM; Magharious MM; Lysko MD; Koeberle PD
    Invest Ophthalmol Vis Sci; 2012 Jun; 53(7):3973-89. PubMed ID: 22531700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Up-regulation of crystallins is involved in the neuroprotective effect of wolfberry on survival of retinal ganglion cells in rat ocular hypertension model.
    Chiu K; Zhou Y; Yeung SC; Lok CK; Chan OO; Chang RC; So KF; Chiu JF
    J Cell Biochem; 2010 May; 110(2):311-20. PubMed ID: 20336662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroprotective effects of Lycium barbarum Lynn on protecting retinal ganglion cells in an ocular hypertension model of glaucoma.
    Chan HC; Chang RC; Koon-Ching Ip A; Chiu K; Yuen WH; Zee SY; So KF
    Exp Neurol; 2007 Jan; 203(1):269-73. PubMed ID: 17045262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protective Effect of Total Panax Notoginseng Saponins on Retinal Ganglion Cells of an Optic Nerve Crush Injury Rat Model.
    Zhong H; Yu H; Chen B; Guo L; Xu X; Jiang M; Zhong Y; Qi J; Huang P
    Biomed Res Int; 2021; 2021():4356949. PubMed ID: 34395614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative profiling of regional protein expression in rat retina after partial optic nerve transection using fluorescence difference two‑dimensional gel electrophoresis.
    Lam C; Li KK; Do CW; Chan H; To CH; Kwong JMK
    Mol Med Rep; 2019 Sep; 20(3):2734-2742. PubMed ID: 31524249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amino-terminal phosphorylation of c-Jun regulates apoptosis in the retinal ganglion cells by optic nerve transection.
    Yoshida K; Behrens A; Le-Niculescu H; Wagner EF; Harada T; Imaki J; Ohno S; Karin M
    Invest Ophthalmol Vis Sci; 2002 May; 43(5):1631-5. PubMed ID: 11980884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical recombinant human Nerve growth factor (rh-NGF) is neuroprotective to retinal ganglion cells by targeting secondary degeneration.
    Guo L; Davis BM; Ravindran N; Galvao J; Kapoor N; Haamedi N; Shamsher E; Luong V; Fico E; Cordeiro MF
    Sci Rep; 2020 Feb; 10(1):3375. PubMed ID: 32099056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Together JUN and DDIT3 (CHOP) control retinal ganglion cell death after axonal injury.
    Syc-Mazurek SB; Fernandes KA; Wilson MP; Shrager P; Libby RT
    Mol Neurodegener; 2017 Oct; 12(1):71. PubMed ID: 28969695
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotective effects of Epigallocatechin-3-gallate (EGCG) in optic nerve crush model in rats.
    Xie J; Jiang L; Zhang T; Jin Y; Yang D; Chen F
    Neurosci Lett; 2010 Jul; 479(1):26-30. PubMed ID: 20471452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retinal genes are differentially expressed in areas of primary versus secondary degeneration following partial optic nerve injury.
    Chiha W; LeVaillant CJ; Bartlett CA; Hewitt AW; Melton PE; Fitzgerald M; Harvey AR
    PLoS One; 2018; 13(2):e0192348. PubMed ID: 29425209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary degeneration of the optic nerve following partial transection: the benefits of lomerizine.
    Fitzgerald M; Bartlett CA; Evill L; Rodger J; Harvey AR; Dunlop SA
    Exp Neurol; 2009 Mar; 216(1):219-30. PubMed ID: 19118550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. GDNF, Ret, GFRalpha1 and 2 in the adult rat retino-tectal system after optic nerve transection.
    Lindqvist N; Peinado-Ramónn P; Vidal-Sanz M; Hallböök F
    Exp Neurol; 2004 Jun; 187(2):487-99. PubMed ID: 15144875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.